B
Bevimi develops cognitive health solutions focused on early detection and mitigation of neuroinflammation and cognitive decline. Its flagship product targets individuals showing initial signs of brain function deterioration, offering a therapeutic or monitoring platform to preserve mental performance. The company monetizes through direct sales of the product to consumers and healthcare providers, positioning itself within the neuro‑health and preventative medicine market.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Bevimi is a cognitive health innovation company focused on strengthening mental acuity and quality of life. Their initial product targets the earliest indicators of cognitive decline and neuroinflammation. The company develops solutions aimed at improving overall brain health and performance.